Merit Medical Systems, Inc.

Merit Medical Systems, Inc.

MMSINYSE / NASDAQHealthcareMid cap

$84.34-$0.07 (-0.1%)

Last close · Data as of Nov 20, 2026

Market cap
$3.8B
P/E
29.3x
EV / EBITDA
12.5x
Revenue
$1.5B
Net margin
8.5%
ROCE
7.6%

-0.6% over the last year

Merit Medical Systems, Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
-7.5%
3M
-6.6%
6M
+30.8%
1Y
-0.6%
5Y
+21.8%

52-week range

Day change -$0.07 (-0.1%) from $84 to $84 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in MMSI, bought on each weekday since 2021.

News & filings

What Merit Medical Systems filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

ConcernReturn on equity of 8.1% against a peer median of 4.0%.

Strengths (1)

  • Operating profit was 7.5 times interest costs.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy.

Read moreShow less

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

Sector
Healthcare
Shares outstanding
59.2M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$3.8B
P/E
29.3x
P/B
2.4x
EV / EBITDA
12.5x
EV / Sales
2.7x
P/S
2.5x
52-week high
$94.20
52-week low
$60.31

Profitability

Operating margin
12.3%
Net margin
8.5%
EBITDA margin
21.9%
ROE
8.1%
ROCE
7.6%
ROA
4.8%
Asset turnover
0.56

Growth

Revenue
$1.5B
Revenue growth, 1Y
11.8%
Revenue CAGR, 3Y
9.6%
Net profit growth, 1Y
6.8%
Free cash flow
$212.5M

Solvency

Current ratio
4.34
Debt / Equity
0.52
Debt / Assets
0.31
CFO / Net profit
2.31
Cash / Market cap
11.9%

Where the revenue went

Of every $100 of FY2025 revenue, $8 was left as net income.

Merit Medical Systems, Inc. income statement flow, FY2025
Merit Medical Systems, Inc. income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$777.6M
RevenueGross profit$738.3M
Gross profitResearch and development$97.3M
Gross profitSelling, general and administrative$455.2M
Gross profitOther operating expenses$10.0k
Gross profitOperating income$185.7M
Operating incomePretax income$170.9M
Operating incomeInterest and other expense$14.8M
Pretax incomeTax and other$42.4M
Pretax incomeNet income$128.5M

Revenue and net profit

Revenue grew 11.8% in FY2025; net profit is the dashed line.

Merit Medical Systems, Inc. revenue and net profit by fiscal year
Merit Medical Systems, Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$1.2B$74.5M
FY2023$1.3B$94.4M
FY2024$1.4B$120.4M
FY2025$1.5B$128.5M

Cash flows

FY2025: $297.4M from operations, $212.5M free after investment (dashed).

Merit Medical Systems, Inc. operating and free cash flow by fiscal year
Merit Medical Systems, Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$114.3M$66.1M
FY2023$145.2M$108.5M
FY2024$220.8M$182.8M
FY2025$297.4M$212.5M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$1.5B+11.8%1Y
EBITDA
$332.0M+12.2%1Y
Net profit
$128.5M+6.8%1Y
Cash from operations
$297.4M+34.7%1Y
Free cash flow
$212.5M+16.3%1Y
Revenue CAGR, 3Y
9.6%
Net profit CAGR, 3Y
19.9%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$1.5B$332.0M$128.5M$212.5M8.1%+11.8%+6.8%

Monthly returns

Month-by-month returns of MMSI across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$2.7B
Liabilities$1.1B
Equity$1.6B
Retained earnings$824.0M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; MMSI highlighted.

P/E against peers

MMSI trades at 29.3x earnings against a peer median of 26.7x.

Not shown (no positive earnings and no EV / Sales): RadNet, Inc.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
Merit Medical Systems, Inc.MMSIthis company$3.8B29.3x2.4x8.1%12.5x
Amneal Pharmaceuticals, Inc.AMRX$4.3B59.9x-60.9x-101.8%11.1x
RadNet, Inc.RDNT$4.2B-222.6x3.8x-1.7%16.7x
Veracyte, Inc.VCYT$4.0B60.1x3.0x5.1%40.9x
Waystar Holding Corp.WAY$3.9B34.6x1.0x2.9%13.6x
Catalyst Pharmaceuticals, Inc.CPRX$3.8B17.9x4.0x22.5%10.6x
ACADIA Pharmaceuticals Inc.ACAD$3.7B9.5x3.0x31.9%30.8x
Organon & Co.OGN$3.5B18.8x4.7x24.9%9.0x
ICU Medical, Inc.ICUI$3.4B4607.1x1.6x0.0%14.7x
Peer median—26.7x3.0x4.0%14.1x

Year-to-date ROI

MMSI since 1 January, against earlier years.

Historical volatility

MMSI's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

Merit Medical Systems, Inc. operating margin by fiscal year
Merit Medical Systems, Inc. operating margin by fiscal year
DateOperating margin
FY20228.8%
FY202310.1%
FY202411.5%
FY202512.3%
LineFY2025
Cost of revenueCost Of Revenue$777.6M
Gross profitGross Profit$738.3M
Operating expensesOperating Expense$552.6M
Research and developmentResearch And Development$97.3M
Selling, general and administrativeSelling General And Administration$455.2M
Total expensesTotal Expenses$1.3B
Pretax incomePretax Income$170.9M

Learn while you research

Academy chapters picked for Merit Medical Systems, Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  3. 03 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  4. 04 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →